HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of subacute infective endocarditis and blood access infection caused by Enterococcus durans.

AbstractBACKGROUND:
Infection by Enterococcus durans (E. durans) is very rare; reported cases are often preceded by therapy or an immunosuppressed state, including infective endocarditis, urinary tract infection, or wound infection. A few reported cases of infective endocarditis exist, with no reports describing involvement of blood access infection.
CASE PRESENTATION:
The patient is an 83-year-old man who had been undergoing hemodialysis for 8 years due to renal failure caused by diabetic nephropathy. He developed infective endocarditis and blood access infection/infective aneurysm due to Enterococcus durans; these conditions were treated with the antibiotic regimen of ampicillin + gentamicin. There have been only a few reported cases of infective endocarditis caused by E. durans, and to our knowledge, this is the first report of blood access infection.
CONCLUSIONS:
We have experienced a case of concurrent infective endocarditis and blood access infection/infective aneurysm caused by E. durans. This is the world's first reported case of blood access infection/infective aneurysm by E. durans.
AuthorsTsuneaki Kenzaka, Noriko Takamura, Ayako Kumabe, Koichi Takeda
JournalBMC infectious diseases (BMC Infect Dis) Vol. 13 Pg. 594 (Dec 17 2013) ISSN: 1471-2334 [Electronic] England
PMID24341733 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Aged, 80 and over
  • Anti-Bacterial Agents (therapeutic use)
  • Bacteremia (drug therapy, etiology, microbiology)
  • Endocarditis, Bacterial (drug therapy, etiology, microbiology)
  • Enterococcus (genetics, isolation & purification, physiology)
  • Humans
  • Male
  • Renal Dialysis (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: